Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Developing a First-void Urine-based Infection Model to Study HPV-specific Antibody-virion Interaction Before and After Vaccination With the Gardasil-9 HPV Vaccine - a Non-randomized Open-label Study.

NCT07407569 is registered in ClinicalTrials.gov with Universiteit Antwerpen as lead sponsor.

NCT NCT07407569
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07407569 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Developing a First-void Urine-based Infection Model to Study HPV-specific Antibody-virion Interaction Before and After Vaccination With the Gardasil-9 HPV Vaccine - a Non-randomized Open-label Study.
Lead sponsor
Universiteit Antwerpen
Phase
Phase 2
Overall status
Recruiting
Start date
March 25, 2026
Completion date
January 1, 2029
Enrollment
50 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

human papilloma virus infection type 16